Prostate Cancer Clinical Trial

Prostate Cancer Screening and Dietary Heterocyclic Amines in African American Men

Summary

RATIONALE: Screening may help doctors find prostate cancer sooner, when it may be easier to treat. The amount of heterocyclic amines in the diet may affect prostate cancer screening results and the risk of prostate cancer.

PURPOSE: This phase II trial is studying prostate cancer screening and dietary heterocyclic amines in African American men.

View Full Description

Full Description

OBJECTIVES:

Estimate dietary heterocyclic amine (HA) exposure in African American men who use HA-forming meats and cooking methods.
Correlate dietary HA exposure with prostate-specific antigen and digital rectal exam screening results (i.e., higher HA exposure with increased abnormality in prostate cancer screening results) in these participants.

OUTLINE: This is a prospective study.

Participants complete a routine medical questionnaire and undergo a detailed dietary interview that focuses on meat consumption, cooking preferences, and other factors that may be associated with prostate cancer risk. Participants then undergo a digital rectal exam (DRE) and blood collection for prostate-specific antigen (PSA) testing (total PSA and % free PSA). Results of PSA testing and DRE, including follow-up instructions (if needed), are sent to the participant 3-4 weeks later.

Blood samples are also examined by phenotypic assays for UV-damage induced nucleotide excision-repair capacity.

PROJECTED ACCRUAL: A total of 800 participants will be accrued for this study.

View Eligibility Criteria

Eligibility Criteria

DISEASE CHARACTERISTICS:

African American male
No previous diagnosis of prostate cancer
Desires prostate cancer screening as a routine preventative medical service

PATIENT CHARACTERISTICS:

Lives in or near Oakland, California
Speaks English
No medical or other disability (e.g., blindness, psychological dysfunction, or amputation) that would preclude study participation

PRIOR CONCURRENT THERAPY:

Not specified

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

800

Study ID:

NCT00354497

Recruitment Status:

Unknown status

Sponsor:

Lawrence Livermore National Laboratory at University of California

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Lawrence Livermore National Laboratory at University of California
Livermore California, 94550, United States More Info
Kenneth T. Bogen, DrPH, MPH, MA, ScD
Contact
925-422-0902
[email protected]
Alta Bates Summit Medical Center - Summit Campus
Oakland California, 94609, United States More Info
Leslie J. Paine
Contact
510-869-8833
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Phase:

Phase 2

Estimated Enrollment:

800

Study ID:

NCT00354497

Recruitment Status:

Unknown status

Sponsor:


Lawrence Livermore National Laboratory at University of California

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider